In cancer biology, midkine has been implicated in tumor progression in glioblastoma and neuroblastoma through ALK/NF-κB and Notch2/Hes1 signaling pathways (Muramatsu and Kadomatsu 2014; Neumaier et al. 2023). This evidence concerns the gene HES1 and cancer.